Monitor the shareholder vote on the merger; DCG's 94.1% voting power post-merger means the combined company will be controlled by a single crypto-focused parent. The reverse acquisition structure and reliance on Nasdaq controlled-company exemptions are key governance features to watch.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 10 $2.40entry
- T+1 · 6d ago −4.18%α −5.49% · $2.30
- T+5 · 11h ago −13.99%α −11.66% · $2.06
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
HeartSciences filed a DEFA14A supplementing its definitive proxy statement for the all-stock merger with Fortitude Mining Holdings, a Zcash-focused crypto miner. The supplement names the nine-member combined company board (seven DCG designees plus two current HeartSciences directors), discloses employment agreements for the incoming CFO ($425K base) and CHRO ($300K base), and updates the pro forma purchase price estimate to $26.1 million. The filing is routine proxy solicitation material ahead of the shareholder vote.
Key Financial Metrics
Key Facts
- Combined company board set at nine members: two from HeartSciences (Simpson, Wells) and seven DCG designees (Higgins, Koster, Leverton, Shifke, Stitzel, Wurtzel, Yacavone).
- Jaime Leverton to be CEO, Mark Shifke to be Chair, Simcha Wurtzel to be Lead Independent Director.
- Erik Ellingson (CFO) employment agreement: $425K base salary, 100% target bonus, option for 0.75% of combined company shares.
- Stephanie Marchioni (CHRO) employment agreement: $300K base salary, 50% target bonus, $150K in RSUs.
- Pro forma purchase price estimated at $26.1 million (equity consideration $20.7M plus $5.4M for pre-combination services on HeartSciences equity awards).
- DCG will hold 94.1% of total voting power post-merger (100% of Class V common, 11.43% of Class A common).
- Combined company will rely on controlled company exemptions from Nasdaq governance rules.
- Three independent directors expected: Higgins, Wells, Wurtzel.
Financial Impact
Estimated purchase consideration of $26.1 million (equity consideration $20.7M plus $5.4M for pre-combination services).
Risk Factors
- Merger may not close if HeartSciences shareholders do not approve the transaction.
- Post-merger, the combined company will be controlled by DCG (94.1% voting power), reducing minority shareholder influence.
- The company will rely on controlled company exemptions from Nasdaq governance requirements, limiting independent board oversight.
- Fortitude's business is tied to Zcash mining and digital asset prices, which are highly volatile.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-117805 |
| Document: 0001213900-26-117805-index-headers.html | 0001213900-26-117805 |
| Document: 0001213900-26-117805-index.html | 0001213900-26-117805 |
| Document: 0001213900-26-117805.txt | 0001213900-26-117805 |
Track record
73 reports on HSCS
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +92.83% at T+20 after the Aug 20, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 17, 2026today S-3/A Bearish 5/10 Entry $2.13 Now $2.06 +3.29% settles Nov 19
- Nov 17, 2026today DEFA14A Neutral 5/10 Entry $2.13 Now $2.06 −3.29% settles Nov 18
- Nov 13, 20264d ago DEFA14A Neutral 5/10 Entry $2.08 to $2.06 Now $2.06 −0.96% ▼ −0.96% +0.05% vs SPY
- Nov 13, 20264d ago DEFA14A Neutral 4/10 Entry $2.13 to $2.08 Now $2.06 −3.06% ▼ −2.12% −0.21% vs SPY
- Nov 13, 20264d ago 8-K/A Bearish 5/10 Entry $2.13 to $2.08 Now $2.06 +3.06% ▲ +2.12% +0.21% vs SPY
- Nov 12, 20265d ago DEFA14A Neutral 4/10 Entry $2.26 to $2.13 Now $2.06 −8.85% ▼ −5.97% −5.61% vs SPY
- Nov 10, 20267d ago DEFA14A Neutral 4/10 Entry $2.30 to $2.26 Now $2.06 −10.24% ▼ −1.53% −1.17% vs SPY
- Nov 10, 20267d ago DEFA14A Neutral 4/10 Viewing Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
- Nov 10, 20267d ago DEFA14A Neutral 3/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
- Nov 9, 20268d ago DEFA14A Neutral 4/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers